Literature DB >> 25086077

Clinical characteristics of and relationship between metabolic components and renal function among patients with early-onset juvenile tophaceous gout.

Chuan-Chin Lu1, Shyi-Kuen Wu1, Han-Yu Chen1, Wei-Sheng Chung1, Meng-Chih Lee1, Chih-Jung Yeh2.   

Abstract

OBJECTIVE: Age of onset of gout has recently decreased; however, patients with early-onset gout remain uncommon, and relevant information is scant. We hypothesized that these patients might exhibit differences in serum urates and other comorbidities compared with adult-onset patients.
METHODS: Early-onset gout patients (i.e., juveniles) with (n = 40) and without tophi (n = 47) were enrolled for study. Their clinical characteristics were compared with those of 353 patients with middle-age-onset tophaceous gout and 64 age-matched healthy participants.
RESULTS: Early-onset gout patients with tophi exhibited significantly higher body mass indices and serum urate levels and lower estimated glomerular filtration rates (eGFR) than did those without tophi. Early-onset gout patients with or without tophi demonstrated significantly abnormal lipid profiles and impaired liver or renal function compared with healthy patients. Serum urate levels and gout duration were identified as the principal determinants of tophi development. The presence of tophi might be crucial in decreasing eGFR, which is inversely related to tophi duration or gout duration. Unexpectedly, the most common site of initial gout attacks in early-onset tophaceous gout patients was the ankle, not the toe, which was the most common site in middle-age-onset tophaceous gout patients. The most common site of first tophi occurrence in early-onset patients was a finger, not a toe, which was the most common site in middle-age-onset patients.
CONCLUSION: Early-onset tophaceous gout patients are more likely to exhibit comorbidities and renal dysfunction than middle-age-onset patients and exhibit distinct first sites of gout attack and tophi occurrence patterns.

Entities:  

Keywords:  COMORBIDITY; GOUT; HYPERURICEMIA; RENAL DYSFUNCTION; TOPHI

Mesh:

Substances:

Year:  2014        PMID: 25086077     DOI: 10.3899/jrheum.131240

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

1.  Metabolic characteristics and renal dysfunction in 65 patients with tophi prior to gout.

Authors:  Chuan-Chin Lu; Shyi-Kuen Wu; Wei-Sheng Chung; Liang-Hung Lin; Ta-Wei Hung; Chih-Jung Yeh
Journal:  Clin Rheumatol       Date:  2017-05-10       Impact factor: 2.980

2.  Risk factors for ulceration over tophi in patients with gout.

Authors:  Jianjun Xu; Cai Lin; Peng Zhang; Jianghui Ying
Journal:  Int Wound J       Date:  2016-10-10       Impact factor: 3.315

Review 3.  The gouty tophus: a review.

Authors:  Ashika Chhana; Nicola Dalbeth
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

4.  Risk factors of ultrasound-detected tophi in patients with gout.

Authors:  Beilei Lu; Qing Lu; Beijian Huang; Cuixian Li; Fengyang Zheng; Peilei Wang
Journal:  Clin Rheumatol       Date:  2020-02-15       Impact factor: 2.980

5.  Clinical Characteristics of Early-Onset Gout in Outpatient Setting.

Authors:  Yan Li; Paramarajan Piranavan; Devi Sundaresan; Robert Yood
Journal:  ACR Open Rheumatol       Date:  2019-08-06

6.  Urate crystal deposition in hyperuricemic children: a dual energy computed tomography study.

Authors:  Qianqian Ying; Jiapei Wang; Yunyan Li; Nan Sun; Yazhen Di; Mengjiao Shen; Shiwei Fu
Journal:  Arch Med Sci       Date:  2021-01-05       Impact factor: 3.318

7.  Presence of tophi is associated with a rapid decline in the renal function in patients with gout.

Authors:  Yoon-Jeong Oh; Ki Won Moon
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

8.  Analysis of Risk Factors for Changes in the Renal Two-Dimensional Image in Gout Patients.

Authors:  Wantai Dang; Xiaohui Xu; Danling Luo; Hui Luo; Jin Hu; Jingguo Zhou; Jian Liu; Lanlan You
Journal:  Int J Gen Med       Date:  2021-10-05

9.  Association Between Chinese Herbal Medicine Therapy and the Risk of Chronic Kidney Disease in Gout Patients.

Authors:  Yan-Zhuan Xiao; Zhi-Zhong Ye; Yuan-Tong Liang; Xin-Peng Chen; Yu-Hsun Wang; Qiang Xu; James Cheng-Chung Wei
Journal:  Front Pharmacol       Date:  2021-05-17       Impact factor: 5.810

10.  Effects of fenofibrate therapy on renal function in primary gout patients.

Authors:  Xinde Li; Wenyan Sun; Jie Lu; Yuwei He; Ying Chen; Wei Ren; Lingling Cui; Zhen Liu; Can Wang; Xuefeng Wang; Lidan Ma; Xiaoyu Cheng; Lin Han; Hailong Li; Hui Zhang; Xuan Yuan; Xiaopeng Ji; Aichang Ji; Tony R Merriman; Changgui Li
Journal:  Rheumatology (Oxford)       Date:  2021-11-03       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.